Protein phosphatase 2A regulates the p38 signaling pathway to affect the migration of astrocytes

Zhang,Lijun; Ma,Pengju; Guan,Qingkai; Meng,Lei; Su,Linlin; Wang,Lina; Zhao,Jianhua; Ji,Sibei

doi:10.3892/mmr.2018.9425

Protein phosphatase 2A regulates the p38 signaling pathway to affect the migration of astrocytes

Authors:
- Lijun Zhang
- Pengju Ma
- Qingkai Guan
- Lei Meng
- Linlin Su
- Lina Wang
- Jianhua Zhao
- Sibei Ji
View Affiliations

Affiliations: Department of Neurology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China, Department of Neurosurgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China
Published online on: August 24, 2018 https://doi.org/10.3892/mmr.2018.9425
Pages: 4328-4334
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect and mechanism of protein phosphatase 2A (PP2A) on the migration of astrocytes. The primary astrocytes of neonatal mice were isolated and cultured in vitro, and treated with the PP2A activator D‑erythro‑sphingosine (DES) (activated group) or inhibitor okadaic acid (inhibitory group). The control group was treated with equal amounts of dimethyl sulfoxide. The activity of PP2A in the cells was detected using a commercial kit and the migration of cells was investigated using a Transwell migration assay. The protein expression of p38, phosphorylated (p)‑p38, matrix metalloproteinase (MMP)‑2 and MMP‑9 was detected by western blotting. Cell migration and the protein expression of p38, p‑p38, MMP‑2 and MMP‑9 was also determined following treatment of astrocytes with the p38 signaling pathway inhibitor SB202190 with or without the PP2A activator DES. The results demonstrated that the activity of PP2A in the PP2A inhibitory group was significantly decreased compared with the control group, while that of the PP2A‑activated cells was significantly increased compared with the control. The protein levels of MMP‑2 and MMP‑9 in the PP2A inhibitory group astrocytes were significantly decreased compared with the control group, while PP2A‑activated astrocytes exhibited significantly increased levels of these proteins. By contrast, the p‑p38 level in PP2A inhibitory group astrocytes was significantly increased compared with the control group, while astrocytes in the activated group exhibited significantly lower levels compared with the control group. Furthermore, the cell migration ability, and MMP‑2 and MMP‑9 protein levels, of astrocytes that received combined treatment with SB202190 and the PP2A activator DES were significantly increased compared with the levels in astrocytes treated with SB202190 alone. The results of the current study indicate that PP2A may negatively regulate the p38 signaling pathway to promote astrocyte migration.

View Figures

View References

1	Furihata T, Ito R, Kamiichi A, Saito K and Chiba K: Establishment and characterization of a new conditionally immortalized human astrocyte cell line. J Neurochem. 136:92–105. 2016. View Article : Google Scholar : PubMed/NCBI
2	Maresca B, Spagnuolo MS and Cigliano L: Haptoglobin modulates beta-amyloid uptake by U-87 MG astrocyte cell line. J Mol Neurosci. 56:35–47. 2015. View Article : Google Scholar : PubMed/NCBI
3	Rajalakshmy AR, Malathi J and Madhavan HN: Serum-derived hepatitis C virus 1a infection of human astrocyte cell line SVG. J Viral Hepat. 23:211–216. 2016. View Article : Google Scholar : PubMed/NCBI
4	Ono K, Suzuki H, Higa M, Tabata K and Sawada M: Glutamate release from astrocyte cell-line GL261 via alterations in the intracellular ion environment. J Neural Transm (Vienna). 121:245–257. 2014. View Article : Google Scholar : PubMed/NCBI
5	Liu Y, Zeng X, Hui Y, Zhu C, Wu J, Taylor DH, Ji J, Fan W, Huang Z and Hu J: Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: Implications for Parkinson's disease. Neuropharmacology. 91:87–96. 2015. View Article : Google Scholar : PubMed/NCBI
6	Seyedzadeh MH, Safari Z, Zare A, Gholizadeh Navashenaq J, Razavi SA, Kardar GA and Khorramizadeh MR: Study of curcumin immunomodulatory effects on reactive astrocyte cell function. Int Immunopharmacol. 22:230–235. 2014. View Article : Google Scholar : PubMed/NCBI
7	Fahn S: Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci. 991:1–14. 2003. View Article : Google Scholar : PubMed/NCBI
8	Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, Hwang D, Masliah E and Lee SJ: Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 285:9262–9272. 2010. View Article : Google Scholar : PubMed/NCBI
9	Snow DM, Lemmon V, Carrino DA, Caplan AI and Silver J: Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol. 109:111–130. 1990. View Article : Google Scholar : PubMed/NCBI
10	Han J and Sun P: The pathways to tumor suppression via route p38. Trends Biochem Sci. 32:364–371. 2007. View Article : Google Scholar : PubMed/NCBI
11	Sun A, Liu M, Nguyen XV and Bing G: P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp Neurol. 183:394–405. 2003. View Article : Google Scholar : PubMed/NCBI
12	Gürsel DB, Banu MA, Berry N, Marongiu R, Burkhardt JK, Kobylarz K, Kaplitt MG, Rafii S and Boockvar JA: Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling. J Neurooncol. 121:19–29. 2015. View Article : Google Scholar : PubMed/NCBI
13	Gonzalez Mde L, Malemud CJ and Silver J: Role of astroglial extracellular matrix in the formation of rat olfactory bulb glomeruli. Exp Neurol. 123:91–105. 1993. View Article : Google Scholar : PubMed/NCBI
14	Juraszek B and Nałęcz KA: Protein phosphatase PP2A-a novel interacting partner of carnitine transporter OCTN2 (SLC22A5) in rat astrocytes. J Neurochem. 139:537–551. 2016. View Article : Google Scholar : PubMed/NCBI
15	Mauch DH, Nägler K, Schumacher S, Göritz C, Müller EC, Otto A and Pfrieger FW: CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294:1354–1357. 2001. View Article : Google Scholar : PubMed/NCBI
16	National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, . Guide for the Care and Use of Laboratory Animals. 8th. National Academies Press (US); Washington, DC: 2011, https://www.ncbi.nlm.nih.gov/books/NBK54050/PubMed/NCBI
17	Kaech S and Banker G: Culturing hippocampal neurons. Nat Protoc. 1:2406–2415. 2006. View Article : Google Scholar : PubMed/NCBI
18	Sofroniew MV and Vinters HV: Astrocytes: Biology and pathology. Acta Neuropathol. 119:7–35. 2010. View Article : Google Scholar : PubMed/NCBI
19	Lin CC, Yang CC, Chen YW, Hsiao LD and Yang CM: Arachidonic acid induces ARE/Nrf2-dependent heme oxygenase-1 transcription in rat brain astrocytes. Mol Neurobiol. 55:3328–3343. 2018. View Article : Google Scholar : PubMed/NCBI
20	Quincozes-Santos A, Bobermin LD, Latini A, Wajner M, Souza DO, Gonçalves CA and Gottfried C: Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1. PLoS One. 8:e643722013. View Article : Google Scholar : PubMed/NCBI
21	Kuse Y, Tsuruma K, Mizoguchi T, Shimazawa M and Hara H: Progranulin deficiency causes the retinal ganglion cell loss during development. Sci Rep. 7:16792017. View Article : Google Scholar : PubMed/NCBI
22	Degos V, Charpentier TL, Chhor V, Brissaud O, Lebon S, Schwendimann L, Bednareck N, Passemard S, Mantz J and Gressens P: Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression. Anesthesiology. 118:1123–1132. 2013. View Article : Google Scholar : PubMed/NCBI
23	Medeiros R, Castello NA, Cheng D, Kitazawa M, Baglietto-Vargas D, Green KN, Esbenshade TA, Bitner RS, Decker MW and LaFerla FM: α7 Nicotinic receptor agonist enhances cognition in aged 3×Tg-AD mice with robust plaques and tangles. Am J Pathol. 184:520–529. 2014. View Article : Google Scholar : PubMed/NCBI
24	Petty EL, Lafon A, Tomlinson SL, Mendelsohn BA and Pillus L: Promotion of cell viability and histone gene expression by the acetyltransferase Gcn5 and the protein phosphatase PP2A in saccharomyces cerevisiae. Genetics. 203:1693–1707. 2016. View Article : Google Scholar : PubMed/NCBI
25	Chica N, Rozalén AE, Pérez-Hidalgo L, Rubio A, Novak B and Moreno S: Nutritional control of cell size by the greatwall-endosulfine-PP2A·B55 pathway. Curr Biol. 26:319–330. 2016. View Article : Google Scholar : PubMed/NCBI
26	Merrill RA, Slupe AM and Strack S: N-terminal phosphorylation of protein phosphatase 2A/Bβ2 regulates translocation to mitochondria, dynamin-related protein 1 dephosphorylation, and neuronal survival. FEBS J. 280:662–673. 2013. View Article : Google Scholar : PubMed/NCBI
27	Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB and Sofroniew MV: Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci. 24:2143–2155. 2004. View Article : Google Scholar : PubMed/NCBI
28	Berns EJ, Sur S, Pan L, Goldberger JE, Suresh S, Zhang S, Kessler JA and Stupp SI: Aligned neurite outgrowth and directed cell migration in self-assembled monodomain gels. Biomaterials. 35:185–195. 2014. View Article : Google Scholar : PubMed/NCBI
29	Yang K, Cao F, Sheikh AM, Malik M, Wen G, Wei H, Ted Brown W and Li X: Up-regulation of Ras/Raf/ERK1/2 signaling impairs cultured neuronal cell migration, neurogenesis, synapse formation, and dendritic spine development. Brain Struct Funct. 218:669–682. 2013. View Article : Google Scholar : PubMed/NCBI
30	Dayer C and Stamenkovic I: Recruitment of matrix metalloproteinase-9 (MMP-9) to the fibroblast cell surface by lysyl hydroxylase 3 (LH3) triggers transforming growth factor-β (TGF-β) activation and fibroblast differentiation. J Biol Chem. 290:13763–13778. 2015. View Article : Google Scholar : PubMed/NCBI
31	Ward MP and Spiers JP: Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: Functional consequences for tumour invasion. Br J Pharmacol. 174:1116–1130. 2017. View Article : Google Scholar : PubMed/NCBI
32	Ghosh S, Kumar A, Tripathi RP and Chandna S: Connexin-43 regulates p38-mediated cell migration and invasion induced selectively in tumour cells by low doses of γ-radiation in an ERK-1/2-independent manner. Carcinogenesis. 35:383–395. 2014. View Article : Google Scholar : PubMed/NCBI
33	Kocić J, Santibañez JF, Krstić A, Mojsilović S, Ilić V and Bugarski D: Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase. Int J Biochem Cell Biol. 45:464–475. 2013. View Article : Google Scholar : PubMed/NCBI
34	Bernet JD, Doles JD, Hall JK, Kelly Tanaka K, Carter TA and Olwin BB: p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat Med. 20:265–271. 2014. View Article : Google Scholar : PubMed/NCBI
35	Wang Y, Xia Y, Kuang D, Duan Y and Wang G: PP2A regulates SCF-induced cardiac stem cell migration through interaction with p38 MAPK. Life Sci. 191:59–67. 2017. View Article : Google Scholar : PubMed/NCBI
36	Zheng HY, Shen FJ, Tong YQ and Li Y: PP2A inhibits cervical cancer cell migration by dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK signaling pathway. Curr Med Sci. 38:115–123. 2018. View Article : Google Scholar : PubMed/NCBI